Get access to our best features
Get access to our best features
Published

Colossal Biosciences Raises $200 Million For De-Extinction Efforts

  • Colossal Biosciences announced it raised $200 million in Series C financing, valuing the company at $10 billion, making it the first Texas startup to reach this valuation according to a spokesperson.
  • The company aims to use gene editing to resurrect extinct animals to combat the extinction crisis, with around 27,000 species going extinct each year.
  • Colossal plans to use the new funding to expand its team, develop new technologies, and enhance its de-extinction efforts, as stated by CEO Ben Lamm.
  • TWG Global led the funding round, highlighting Colossal's role in advancing conservation and technology innovations in species preservation, according to CEO Mark Walter.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)